Learn More
Medchemexpress LLC (rel)-Tivantinib ((rel)-ARQ 197) | 905853-99-8 | 96.45% | C23H19N3O2 | 50 MG

Supplier: Medchemexpress LLC HY7749350MG
(rel)-Tivantinib, also known as (rel)-ARQ 197, is a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET. This compound is known for its role in inhibiting cancer cell growth and proliferation by targeting the c-MET pathway, which is often dysregulated in various cancers. It has been investigated for its potential as an anti-cancer agent due to its ability to block c-MET signaling.
- Potent and highly selective c-MET inhibitor.
- Inhibits cancer cell growth and proliferation.
- Targets the c-MET signaling pathway.
- Investigated as a potential anti-cancer agent.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.